Provided by Tiger Trade Technology Pte. Ltd.

Ashland

53.61
+2.805.51%
Post-market: 53.610.00000.00%19:52 EDT
Volume:815.23K
Turnover:43.23M
Market Cap:2.45B
PE:-3.54
High:53.75
Open:51.57
Low:51.15
Close:50.81
52wk High:65.65
52wk Low:45.21
Shares:45.76M
Float Shares:41.77M
Volume Ratio:1.07
T/O Rate:1.95%
Dividend:1.65
Dividend Rate:3.08%
EPS(TTM):-15.1257
EPS(LYR):-18.3696
ROE:-29.98%
ROA:2.09%
PB:1.31
PE(LYR):-2.92

Loading ...

Press Release: Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December

Dow Jones
·
Nov 14, 2025

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

GlobeNewswire
·
Nov 13, 2025

Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs

GlobeNewswire
·
Nov 13, 2025

Ascentage Pharma (SEHK:6855): Evaluating Valuation After ASH Meeting Spotlights Pipeline Progress

Simply Wall St.
·
Nov 13, 2025

Press Release: SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Nov 13, 2025

Ashland : Deutsche Bank Raises Target Price to $58 From $55

THOMSON REUTERS
·
Nov 12, 2025

Ashland Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Nov 11, 2025

Shield Therapeutics to Present Pediatric PK Results at ASH Conference

TIPRANKS
·
Nov 11, 2025

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 10, 2025

Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)

GlobeNewswire
·
Nov 10, 2025

Galecto Announces Acquisition of Damora Therapeutics

GlobeNewswire
·
Nov 10, 2025

Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025

Dow Jones
·
Nov 07, 2025

Evercore ISI Sticks to Its Hold Rating for Ashland (ASH)

TIPRANKS
·
Nov 06, 2025

Ashland Global’s Resilient Earnings Amid Challenges

TIPRANKS
·
Nov 06, 2025

Stock Track | Ashland Soars 5.10% Despite Q4 Sales Decline as Margins Improve

Stock Track
·
Nov 06, 2025

Stock Track | Ashland Soars 5.10% Despite Q4 Sales Decline as Margins Improve

Stock Track
·
Nov 06, 2025

HK Stock Movement | LEADS BIOLABS-B (09887) Rises Over 3% as Five Hematology Research Findings Presented at 2025 ASH Annual Meeting

Stock News
·
Nov 05, 2025

Ashland Reports Q4 2025 Results Amid Sales Decline

TIPRANKS
·
Nov 05, 2025

Ashland reports Q4 adjusted EPS $1.08, consensus $1.26

TIPRANKS
·
Nov 05, 2025

Ashland sees FY26 revenue $1.835B-$1.905B, consensus $1.87B

TIPRANKS
·
Nov 05, 2025